Lineage Cell Therapeutics, Inc. Finance Lease, Liability, Current
Lineage Cell Therapeutics, Inc. (LCTX) had Finance Lease, Liability, Current of $33.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, Current $33.00K.
- 2026-03-31: Finance Lease, Liability, Current $32.00K.
- 2025-12-31: Finance Lease, Liability, Current $37.00K.
- 2025-09-30: Finance Lease, Liability, Current $43.00K.
| Period end | Finance Lease, Liability, Current | Finance Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $33.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $32.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $37.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $43.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $56.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $55.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $54.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $46.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $49.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $52.00K 10-K · filed 2025-03-10 | |
| 2023-09-30 | $55.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $54.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $51.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $36.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $25.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $29.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $31.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $30.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $17.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $17.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $786.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $16.00K 10-K · filed 2022-03-10 | $762.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $488.00K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $1.24M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.24M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.22M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $1.14M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $956.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $954.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $237.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |